BioLase Technology, Inc. (Nasdaq: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on improving dental procedures, has acquired PAClive, a premier dental teaching institute, from Discus Dental, Inc., a leading direct distribution manufacturer of dental products. PAClive, one of dentistry's premier live-patient, hands-on continuing education programs in the United States, was established in 1998 by Dr. William Dorfman, founder of Discus Dental. "We're proud of PAClive's accomplishments over the past 6 years. We've helped change the lives of thousands of dental professionals, as well as their patients," says Dr. Dorfman. "We're pleased to hand over the reigns of the program to a solid organization. We believe BioLase is going to continue to uphold the standards of excellence that have defined the PAClive experience, and help take the program to new heights."
Jeffrey W. Jones, BioLase President and CEO, commented, "PAClive is a respected forum, well known in the industry for advancing dentistry to the benefit of both practitioners and patients. PAClive has a strong contingent of instructors, sponsors and suppliers that BioLase plans to continue working with to grow the PAClive tradition and to broaden its course offerings. Additionally, PAClive is an ideal forum to showcase BioLase's Waterlase and LaserSmile dental laser systems."
About Discus Dental, Inc.
Founded in 1993, Discus Dental is one of the leading direct manufacturing sellers of dental products in North America. The company is a leading manufacturer and direct distributor of professional dental products in the areas of tooth whitening and breath control; a leader in the areas of impression materials, site registration materials, curing lights, restorative materials, prescription home fluorides, continuing education, practice enhancement services and practice management software. Discus Dental is headquartered in Culver City, California. More information is available at www.discusdental.com.
About BioLase BioLase Technology, Inc. (http://www.biolase.com) is a medical technology company that designs, manufacturers and markets proprietary dental laser systems that allow dentists, oral surgeons and other specialists to perform a broad range of common dental procedures, including cosmetic applications. The company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase system, is the best selling dental laser system. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The company also offers the LaserSmile system, which uses a laser to perform soft tissue and cosmetic procedures, including tooth whitening. In May 2003, the company acquired the American Dental Laser product line, including the Diolase and Pulsemaster systems, which can be used for common soft tissue procedures.
Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward- looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.